The effect of paradox therapy on anxiety, rumination, and ego strength in adolescents with body dysmorphic symptoms.

The effectiveness of paradox therapy on satisfaction, rumination, and ego strength in adolescents with body dysmorphic symptoms.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251004067501N1

Enrollment

Registered

2025-10-25

Start date

2025-10-30

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body dysmorphic disorder. Obsessive-compulsive disorder

Interventions

Intervention 1: Control group:Includes 20 female high school students who have body dysmorphic disorder but are not receiving any intervention. Intervention 2: Intervention group: The first interventi

Eligibility

Sex/Gender

Female

Age

13 Years to 18 Years

Inclusion criteria

Inclusion criteria: Having symptoms of body dysmorphic disorder according to DSM5_TR. Adolescent age between 13 and 18 years. Voluntary consent to participate in research and treatment.

Exclusion criteria

Exclusion criteria: Having severe psychological disorders and a history of medication use and psychiatric hospitalization. The presence of severe congenital or non-congenital physical defects that are visibly visible. Addiction to any stimulant or addictive substance.

Design outcomes

Primary

Measure	Time frame
Ego Strength Score in Dr. Besharat's Ego Strength Questionnaire (ESS). Timepoint: Before the intervention, after the intervention, and two months after the intervention. Method of measurement: Dr. Besharat's Ego Strength Questionnaire (ESS).;A score obtained from the modified Yale-Brown Obsessive Compulsive Disorder Inventory to prevent body deformity. Timepoint: Before the intervention, after the intervention, and two months after the intervention. Method of measurement: Revised Yale-Brown Obsessive Compulsive Disorder Scale.;Anxiety score in the Depression, Anxiety, and Stress Scale(DASS21). Timepoint: Before the intervention, after the intervention, and two months after the intervention. Method of measurement: Depression, Anxiety, and Stress Assessment Questionnaire DASS21.;Rumination score on the Nalen Hoeksma and Maru Rumination Questionnaire (RSQ). Timepoint: Before the intervention, after the intervention, and two months after the intervention. Method of measurement: Nalen Hoeksma and Maru Rumination Questionnaire (RSQ).	—

Measure

Time frame

Ego Strength Score in Dr. Besharat's Ego Strength Questionnaire (ESS). Timepoint: Before the intervention, after the intervention, and two months after the intervention. Method of measurement: Dr. Besharat's Ego Strength Questionnaire (ESS).;A score obtained from the modified Yale-Brown Obsessive Compulsive Disorder Inventory to prevent body deformity. Timepoint: Before the intervention, after the intervention, and two months after the intervention. Method of measurement: Revised Yale-Brown Obsessive Compulsive Disorder Scale.;Anxiety score in the Depression, Anxiety, and Stress Scale(DASS21). Timepoint: Before the intervention, after the intervention, and two months after the intervention. Method of measurement: Depression, Anxiety, and Stress Assessment Questionnaire DASS21.;Rumination score on the Nalen Hoeksma and Maru Rumination Questionnaire (RSQ). Timepoint: Before the intervention, after the intervention, and two months after the intervention. Method of measurement: Nalen Hoeksma and Maru Rumination Questionnaire (RSQ).

—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtena Fadaee

Islamic Azad University

atenafadaee79@gmail.com+98 21 7700 2062

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026